Key facts
- It has raised $15.0M; the latest was Later Stage VC ($10.1M) in Oct 2025.
- Notable investors include Innovate UK, BGF (Financial Services), Parkwalk Advisors, Cambridge Angels, Meltwind Advisory — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Psyomics
- ·The full record, as it builds
Funding rounds
No funding rounds for Psyomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Psyomics
Developer of web-based assessment triage designed for diagnostic and pathway prediction for mental health conditions. The company's services combine digital profiling with the latest advances in biological research to enhance diagnostic accuracy and help primary care practitioners efficiently manage their patient's mental health needs by digitally mirroring a psychiatric assessment at the first point of contact, enabling patients to get enhanced recovery from mental health disorders.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2015
- Employees
- 28
- Website
- psyomics.com/
- Ownership
- Privately Held (backing)
Psyomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Psyomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Psyomics in its N-PORT filings yet. We sweep new filings monthly.